Background Lung clearance index (LCI2.5) is a marker of overall lung ventilation inhomogeneity and has proven to be able to detect early peripheral damage in subjects with cystic fibrosis (CF), with greater sensitivity than conventional spirometry. Combining its sensitivity with the output of an incremental exercise testing, we hypothesized that any sign of ventilation inhomogeneity in subjects without severe airflow obstruction and with a normal exercise tolerance could be relevant for the CF team, tracking early lung disease and potential exercise limiting factors. Methods Patients with CF in clinical stable conditions were recruited between 2015 and 2017. Available spirometry, nitrogen multiple-breath washout test and symptoms-limited ex...
(1) Background: Pulmonary exacerbation (PEx) is one of the main factors affecting the quality of lif...
Introduction: Decreased respiratory muscle strength in patients with cystic fibrosis (CF) may cause ...
Background: Nocturnal hypoxemia adversely affects outcomes in patients with cystic fibrosis (CF). Al...
Based on serial lung function measurements performed in 142 children (68 males; 74 females) with cys...
Clinical research in cystic fibrosis (CF) requires study endpoints that are sensitive to airways dis...
Pulmonary exacerbations are important clinical events for cystic fibrosis (CF) patients. Studies ass...
We studied distribution of ventilation in patients with cystic fibrosis (CF) who had not had an exac...
SummaryIntroductionLung disease remains the main cause of morbidity and mortality in patients with C...
We investigated the extent of convective ventilation heterogeneity contributing to the observed lung...
BACKGROUND: Lung clearance index (LCI) is a valuable research tool in cystic fibrosis (CF) but clini...
The lung clearance index (LCI) is a lung function parameter derived from the multiple-breath washout...
Lung Clearance Index (LCI), a measure of ventilation inhomogeneity, reflects disease in distal airwa...
The lung clearance index (LCI) is a lung function parameter derived from the multiple-breath washout...
OBJECTIVE: To investigate the presence of dynamic hyperinflation after the Modified Shuttle Test (M...
CF is a polymorphic disease whose evolution is marked by pulmonary pathology. Distal obstruction, de...
(1) Background: Pulmonary exacerbation (PEx) is one of the main factors affecting the quality of lif...
Introduction: Decreased respiratory muscle strength in patients with cystic fibrosis (CF) may cause ...
Background: Nocturnal hypoxemia adversely affects outcomes in patients with cystic fibrosis (CF). Al...
Based on serial lung function measurements performed in 142 children (68 males; 74 females) with cys...
Clinical research in cystic fibrosis (CF) requires study endpoints that are sensitive to airways dis...
Pulmonary exacerbations are important clinical events for cystic fibrosis (CF) patients. Studies ass...
We studied distribution of ventilation in patients with cystic fibrosis (CF) who had not had an exac...
SummaryIntroductionLung disease remains the main cause of morbidity and mortality in patients with C...
We investigated the extent of convective ventilation heterogeneity contributing to the observed lung...
BACKGROUND: Lung clearance index (LCI) is a valuable research tool in cystic fibrosis (CF) but clini...
The lung clearance index (LCI) is a lung function parameter derived from the multiple-breath washout...
Lung Clearance Index (LCI), a measure of ventilation inhomogeneity, reflects disease in distal airwa...
The lung clearance index (LCI) is a lung function parameter derived from the multiple-breath washout...
OBJECTIVE: To investigate the presence of dynamic hyperinflation after the Modified Shuttle Test (M...
CF is a polymorphic disease whose evolution is marked by pulmonary pathology. Distal obstruction, de...
(1) Background: Pulmonary exacerbation (PEx) is one of the main factors affecting the quality of lif...
Introduction: Decreased respiratory muscle strength in patients with cystic fibrosis (CF) may cause ...
Background: Nocturnal hypoxemia adversely affects outcomes in patients with cystic fibrosis (CF). Al...